Response to Pyrotinib in a Patient with Metastatic Bladder Urothelial Carcinoma Harboring HER2 V842I Mutation: A Case Report

BACKGROUND: The highest incidence of human epidermal growth factor receptor 2 (HER2) mutations has been observed in bladder cancer (BC). However, the function of HER2 mutation in tumor progression and metastasis remains unclear. Currently, no responses to the pan-HER kinase inhibitor were observed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Suyao, Liu, Qing, Liu, Mengling, Liu, Tianshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528799/
https://www.ncbi.nlm.nih.gov/pubmed/36200096
http://dx.doi.org/10.2147/CMAR.S365951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528799/
https://www.ncbi.nlm.nih.gov/pubmed/36200096
http://dx.doi.org/10.2147/CMAR.S365951

Ejemplares similares